Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Ambry Genetics provides industry-leading genetic testing for hereditary cancer and rare diseases, offering tests across oncology, cardiology, neurology, exome and rare diseases with resources for patients, providers, and billing. It supports testing and diagnosis through programs like Patient for Life and CARE, plus tools such as Ambry Classifi and +RNAinsight, and offers pharma services and scientific collaborations. The company positions itself as a partner to healthcare professionals to advance personalized medicine and improve treatment decisions with advanced genetic insights.
Sources
ambrygen.com shapes more of what AI says about Ambry Genetics than any other source, at 100% of its citations.
The market map
Consumer Genomics Products and Services →Where AI ranks Ambry Genetics